Related references
Note: Only part of the references are listed.The Evolving Diagnostic and Treatment Landscape of NTRK-Fusion-Driven Pediatric Cancers
David S. Shulman et al.
PEDIATRIC DRUGS (2020)
Glioblastomas harboring gene fusions detected by next-generation sequencing
Ha Young Woo et al.
BRAIN TUMOR PATHOLOGY (2020)
Molecular and clinicopathologic features of gliomas harboring NTRK fusions
Matthew Torre et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibit ROS1/TRK/ALK Solvent-Front Mutations
Alexander Drilon et al.
CANCER DISCOVERY (2018)
High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol
C. Dufour et al.
EUROPEAN JOURNAL OF CANCER (2006)
Share Paper
